Cargando…
Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures
Shortening the turn-around time (TAT) of positive blood culture (BC) identification (ID) and susceptibility results is essential to optimize antimicrobial treatment in patients with sepsis. We aimed to evaluate the impact on antimicrobial prescription of a modified workflow of positive BCs providing...
Autores principales: | Verroken, Alexia, Defourny, Lydwine, le Polain de Waroux, Olivier, Belkhir, Leïla, Laterre, Pierre-François, Delmée, Michel, Glupczynski, Youri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881997/ https://www.ncbi.nlm.nih.gov/pubmed/27228001 http://dx.doi.org/10.1371/journal.pone.0156299 |
Ejemplares similares
-
Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures
por: Verroken, Alexia, et al.
Publicado: (2016) -
Performance Evaluation of the MBT STAR(®)-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS
por: Anantharajah, Ahalieyah, et al.
Publicado: (2019) -
Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS
por: Dortet, Laurent, et al.
Publicado: (2020) -
MALDI-TOF MS monitoring of PBMC activation status in sepsis
por: Daumas, Aurélie, et al.
Publicado: (2018) -
Editorial: MALDI-TOF MS Application for Susceptibility Testing of Microorganisms
por: Becker, Karsten, et al.
Publicado: (2020)